Immunodiagnostic Systems (IDS)

Immunodiagnostic Systems (IDS) is a global leader in the medical diagnostics industry. Founded in 1977, IDS is dedicated to developing innovative automated and manual assays in the clinical areas of bone and calcium metabolism, growth, hypertension, and chronic kidney disease. Their flagship product, the IDS-iSYS system, is renowned for its flexibility and efficiency in specialty immunoassay testing. Based in the UK, IDS has subsidiaries in Germany, France, Belgium, Italy, and the Nordic countries, and serves other key diagnostic markets such as Spain, Australia, and Japan through a network of experienced distributors. Specializing in health care, IDS offers specialty endocrinology, autoimmunity, infectious disease, and allergy immunoassay solutions. Although specific details on their last investment and investors are not available, IDS continues to be a prominent player in the global medical diagnostics market.